On December 9, 2022, Giulia C. Kennedy, Ph.D, Global Chief Scientific Officer and Chief Medical Officer of Veractye, Inc. and the company agreed that she would depart from the company, effective December 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.65 USD | -3.55% | -0.48% | -24.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.94% | 1.58B | |
-41.97% | 7.92B | |
-4.31% | 2.18B | |
-21.69% | 1.97B | |
+31.45% | 1.14B | |
+26.75% | 792M | |
-9.83% | 690M | |
-26.33% | 532M | |
+3.38% | 303M | |
-16.34% | 160M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Veracyte, Inc. Announces Resignation of Giulia C. Kennedy as Global Chief Scientific Officer and Chief Medical Officer